Works matching IS 07423071 AND DT 2013 AND VI 30 AND IP 11


Results: 19
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN<sup>®</sup> Basal-Bolus Type 1): 2-year results of a randomized clinical trial

    Published in:
    Diabetic Medicine, 2013, v. 30, n. 11, p. 1293, doi. 10.1111/dme.12243
    By:
    • Bode, B. W.;
    • Buse, J. B.;
    • Fisher, M.;
    • Garg, S. K.;
    • Marre, M.;
    • Merker, L.;
    • Renard, E.;
    • Russell‐Jones, D. L.;
    • Hansen, C. T.;
    • Rana, A.;
    • Heller, S. R.
    Publication type:
    Article
    17
    18
    19